- Home
- AMR vs IRON Comparison
AMR vs IRON Comparison
Compare AMR & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMR
- IRON
- Stock Information
- Founded
- AMR 2016
- IRON 2017
- Country
- AMR United States
- IRON United States
- Employees
- AMR N/A
- IRON N/A
- Industry
- AMR Coal Mining
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- AMR Energy
- IRON Health Care
- Exchange
- AMR Nasdaq
- IRON Nasdaq
- Market Cap
- AMR 2.1B
- IRON 2.1B
- IPO Year
- AMR N/A
- IRON N/A
- Fundamental
- Price
- AMR $169.27
- IRON $67.78
- Analyst Decision
- AMR Buy
- IRON Strong Buy
- Analyst Count
- AMR 4
- IRON 10
- Target Price
- AMR $168.00
- IRON $97.80
- AVG Volume (30 Days)
- AMR 302.9K
- IRON 380.9K
- Earning Date
- AMR 11-06-2025
- IRON 11-11-2025
- Dividend Yield
- AMR N/A
- IRON N/A
- EPS Growth
- AMR N/A
- IRON N/A
- EPS
- AMR N/A
- IRON N/A
- Revenue
- AMR $2,371,475,000.00
- IRON N/A
- Revenue This Year
- AMR N/A
- IRON N/A
- Revenue Next Year
- AMR $25.30
- IRON N/A
- P/E Ratio
- AMR N/A
- IRON N/A
- Revenue Growth
- AMR N/A
- IRON N/A
- 52 Week Low
- AMR $97.41
- IRON $30.82
- 52 Week High
- AMR $255.04
- IRON $68.79
- Technical
- Relative Strength Index (RSI)
- AMR 62.56
- IRON 69.97
- Support Level
- AMR $163.36
- IRON $65.26
- Resistance Level
- AMR $176.81
- IRON $68.79
- Average True Range (ATR)
- AMR 6.83
- IRON 2.67
- MACD
- AMR 0.39
- IRON 0.53
- Stochastic Oscillator
- AMR 70.08
- IRON 88.97
About AMR Alpha Metallurgical Resources Inc.
Alpha Metallurgical Resources Inc is a Tennessee-based coal mining company with operations across Virginia and West Virginia. The company's portfolio of mining operations consists of underground mines, surface mines, and coal preparation plants. It produces low-ash metallurgical coal, including High-Vol. A, Mid-Vol., High-Vol. B, and Low-Vol. coal, which is shipped to domestic and international coke and steel producers. The reportable segment of the company is Met. It extracts, processes and markets met and thermal coal from deep and surface mines for sale to steel and coke producers, industrial customers, and electric utilities.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.